Abstract:AIM: To investigate the anti-human hepatocellular car-cinoma (HCC) activity of docetaxel and determine the potential radiosensitizing effect of docetaxel in vivo, and to further explore the mechanism of docetaxel-induced cell growth inhibition, apoptosis and radiosen-sitization at gene level.METHODS: Nude mice bearing HCC with a diameter of about 0.8 cm in the leg received 33 mg/kg docetaxel intraperitoneally, 10 Gy (5 Gy once) tumor irradiation, or both (radiation given 24 and 48 h after docetaxel treatment). The regression and regrowth of the tumors were followed until the tumor diameter reached 1.4 cm approximately. Absolute growth delay (AGD), which was defi ned as the time in days for tumors treated with docetaxel to grow from 0.8 to 1.4 cm in diameter mi-nus the time in days for untreated tumors to reach the same size, was used to evaluate the antitumor effect ofdocetaxel. Normalized growth delay (AGD), which was def ined as the time in days for tumors treated with both docetaxel and irradiation to grow from 0.8 to 1.4 cm in diameter minus the time in days for tumors treated with docetaxel alone to reach the same size, and the en-hancement factor (ratio of NGD to AGD for irradiation alone) was used to assess the effect of the combined docetaxel plus radiation treatment. Real-time qutitative reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the expression of bcl-2 and p21 genes in HCC cells before and after decetaxel treatment.RESULTS: The tumors in docetaxel treated alone and irradiation treated alone groups needed 35 and 29 d to reach 14 cm in diameter, respectively, while the ones in the control group needed 23 d. So the AGD was 12 and 6 d, respectively. The combined administra-tion of docetaxel and irradiation resulted in signifi cant growth delay (47 d), and the EF was 2.0, indicating that docetaxel enhanced tumor radioresponse. At 20 d, the sizes of the tumors in docetaxel treated alone group and combination of docetaxel and irradiation group were significantly smaller than those in the controls (P = 0.008, P = 0.005), and the size in the combination group was also smaller than that in the irradiation alone group (P = 0.002). Real time quantita-tive RT-PCR analyses revealed that mRNAs of p21 in the docetaxel treated SMMC-7721 cells at most of the time points were increased, as compared with those in the control cells. In contrast, bcl-2 expression in the docetaxel treated SMMC-7721 cells was suppressed as compared with that in the controls.CONCLUSION: Docetaxel can inhibit the growth of HCC and enhance the tumor response to fractionated irradiation in vivo by down-regulation of bcl-2 expres-sion and up-regulation of p21 expression..

Sensitizing Effect of Chemotherapy of Isorhapontigenin through Down-Regulating Expression of X-Linked Inhibitor of Apoptosis

Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells

Induction of Mir-137 by Isorhapontigenin (iso) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both in Vitro and in Vivo

Downregulation of long non-coding RNA UCA 1 is associated with the anticancer effects of isorhapontigenin on human bladder cancer cells

Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway.

Effects of down-regulating expression of X-linked inhibitor of apoptosis on chemotherapy induced apoptosis of gastric cancer cells

Isorhapontigenin Induced Cell Growth Inhibition and Apoptosis by Targeting EGFR‐related Pathways in Prostate Cancer

Enhanced Anti-Tumor Efficacy and Mechanisms Associated with Docetaxel-Piperine Combination- in Vitro and in Vivo Investigation Using a Taxane-Resistant Prostate Cancer Model.

Effect of paclitaxel and gemcitabine on the expression of nucleosomal binding protein 1 in bladder cancer cell line T24

Antitumor and radiosensitizing effect of docetaxel on human hepatocellular carcinoma and its mechanisim in vivo

ISO-upregulated BECN1 specifically promotes LC3B-dependent autophagy and anticancer activity in invasive bladder cancer

Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b

Relationship between the effect of docetaxel inducing apoptosis of non-small-cell lung cancer cell and the intracellular level of reactive oxygen

Isorhapontigenin (ISO) Inhibited Cell Transformation by Inducing G0/G1 Phase Arrest Via Increasing MKP-1 Mrna Stability.

In Vivo Study on the Effect Docetaxel on Apoptosis and Proliferation Inhibition of Murine-phenotypic Angiosarcoma (ISOS-1) Cell

Inhibitory Effect of Docetaxel on the Proliferation of Human Hemangiosarcoma Cell Line

The Inhibitory effect of Docetaxel on the proliferation of human lung cancer cell A549 cells in vitro

The study of the inhibits and apoptosis induced by docetaxel to human gastric cancer cells

Studies on Antisense Oligodeoxynucleotide Targeting Survivin Inducing Apoptosis of Human Bladder Transitional Cell Carcinoma T24 Cell Lines

MP-12.20: Downregulation of X-linked inhibitor of apoptosis protein sensitizes bladder cancer cell to chemotherapeutics

Autophagy inhibition enhances isorhamnetin‑induced mitochondria‑dependent apoptosis in non‑small cell lung cancer cells